Back to Trades
Newton Charles W.
DirectorCIK 0001866219
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 4
- Active
- 2025–2026
Newton Charles W., Director, accounts for 5 disclosed filings worth $304.8K, spread across 4 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $23.6K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jun 23 | NVAX NOVAVAX INC | Newton Charles W. | Director | Award | $194.2K |
| Jun 15 | KROS Keros Therapeutics, Inc. | Newton Charles W. | Insider | Sell | $5.5K |
| Jun 9 | CHRS Coherus Oncology, Inc. | Newton Charles W. | Insider | Grant | $87.0K |
| Aug 22 | LYEL Lyell Immunopharma, Inc. | Newton Charles W. | Insider | Sell | $15.3K |
| Aug 13 | LYEL Lyell Immunopharma, Inc. | Newton Charles W. | Insider | Sell | $2.8K |
5 filings